InvestorsHub Logo
Followers 3
Posts 1093
Boards Moderated 0
Alias Born 09/18/2009

Re: XenaLives post# 16977

Wednesday, 03/06/2013 6:53:54 PM

Wednesday, March 06, 2013 6:53:54 PM

Post# of 17111
Two Seattle attorneys accused in alleged stock scam


By LEVI PULKKINEN <mailto:levipulkkinen@seattlepi.com>
SEATTLEPI.COM STAFF

Federal regulators have filed a lawsuit against two Seattle attorneys
accused in an alleged stock scam involving nonexistent anti-aging products.
According to a documents released Monday by the Securities and Exchange
Commission, Seattle attorneys David Otto and Todd Van Siclen were hired in
2004 by a company called MitoPharm, which purported to produce herbal
nutritional supplements and beverages.
Attorneys for the SEC say Otto, 50, gained control of MitoPharm through a
complex series of mergers and stock sales.
The SEC attorneys allege in court documents that Otto, Van Siclen and others
then began promoting the company's supposed products -- Restorade and
Stamina Solution -- in 2007, at a time when the company had no way of
producing or distributing either item.
In the months that followed, SEC attorneys claim the company sent out a
flurry of press releases aimed at boosting the value of MitoPharm stock. At
the same time, Otto allegedly began off-loading shares of the company.
The SEC claims the move netted Otto nearly $1.3 million while crushing
MitoPharm's stock price, driving it from a per-share high in August 2007 of
$2.31 to 5 cents a share in November 2007.
In addition to Otto and Van Siclen, MitoPharm CEO Pak Peter Cheung of
Vancouver, B.C., and stock promoter Charles Bingham are named in the suit.
The SEC has asked that financial penalties be imposed on the men, as well as
administrative sanctions barring them from involvement in similar dealings.
Levi Pulkkinen can be reached at 206-448-8348 or
levipulkkinen@seattlepi.com.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.